Weight loss surgery on the NHS: who qualifies and how to get referred
NHS weight loss surgery costs you nothing at the point of use, because access to NHS services is based on clinical need rather than ability to pay. What limits it is eligibility and capacity. In England, your GP should refer you for a full assessment if your BMI is 40 kg/m² or more, or between 35 and 39.9 kg/m² alongside a significant health condition that could improve with weight loss, and if you agree to the long-term follow-up that surgery requires. That referral leads to an assessment by a specialist overweight and obesity management service, not straight to an operating list.
That distinction matters because eligibility and treatment are far apart. Around 7.3% of the English population, roughly 3.21 million people, meet the clinical criteria, yet only 0.20% of that eligible group has metabolic surgery in a given year, with regional rates ranging from 0.08% to 0.41% (Currie et al., 2021). Knowing how the pathway works, and where it stalls, tells you what to expect and what your options are. This article covers the criteria, the referral route, the variation across the four UK nations, what you commit to afterwards, and what happens if weight loss surgery on the NHS is not open to you.
Who can have weight loss surgery on the NHS?
The criteria come from NICE guideline NG246, Overweight and obesity management, published on 14 January 2025, which replaced the older CG189 guidance. NG246 sets out when a clinician should offer a referral for assessment, and when that assessment should be brought forward.
| BMI (kg/m²) | NHS route |
|---|---|
| 40 or more | Referral for assessment |
| 35 to 39.9 plus a condition | Referral for assessment |
| 35+, new type 2 diabetes | Expedited assessment |
| 30 to 34.9, new diabetes | Expedited considered |
Recommendation 1.18.1 attaches a second condition to the BMI threshold: you must agree to the necessary long-term follow up after surgery, for example lifelong annual reviews. The health conditions NICE gives as examples in Box 2 are cardiovascular disease, hypertension, idiopathic intracranial hypertension, non-alcoholic fatty liver disease with or without steatohepatitis, obstructive sleep apnoea and type 2 diabetes. That list is explicitly not exhaustive, so a condition outside it can still count if the multidisciplinary team accepts that weight loss would improve it.
Lower thresholds for some family backgrounds
Recommendation 1.18.2 asks clinicians to consider referral for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background using a BMI threshold reduced by 2.5 kg/m². The reasoning given is that these groups are prone to central adiposity and that their cardiometabolic risk appears at a lower BMI. In practice this means a BMI of 37.5 can count for as much in a referral decision as a BMI of 40 in another patient.
Recent-onset type 2 diabetes moves you up the queue
NICE draws a distinction between a standard referral and an expedited one. An expedited assessment should be offered where BMI is 35 or more and type 2 diabetes was diagnosed within the past 10 years, provided you are also receiving or will receive assessment in a specialist service (1.18.3). It should be considered at a BMI of 30 to 34.9 with the same recency of diabetes (1.18.4), and at a further 2.5 kg/m² lower for the family backgrounds listed above (1.18.5).
The clinical case for prioritising these patients comes from long-term trial data. In a ten-year randomised follow-up, 37.5% of surgically treated patients maintained diabetes remission across the whole decade, against 5.5% in the medical therapy group, and the surgical groups had markedly fewer diabetes-related complications (Mingrone et al., 2021).
How to get referred: the NHS pathway step by step
Start with your GP. The consultation is easier if you bring what the decision rests on: your current height and weight, your highest recorded weight, any diagnosed conditions, and a record of what you have already tried. NHS guidance frames eligibility partly around having tried to lose weight through a healthy diet, exercise and medicine, so a documented history of previous attempts supports your case.
Your GP refers you to a specialist overweight and obesity management service. This is the stage previously labelled tier 3, and NG246 dropped that label deliberately: the guideline committee took the view that requiring people to complete specific measures before referral would create an unjustified barrier to treatment. The service should include, or have access to, professionals able to carry out medical, nutritional, psychological and surgical assessments.
A multidisciplinary team assesses you. Recommendation 1.18.7 lists what that assessment covers: your medical needs and existing comorbidities, your nutritional status and eating behaviours, psychological needs that would support adherence to postoperative care, your previous attempts to manage your weight, factors such as language barriers, learning disabilities, neurodevelopmental conditions and deprivation, any individual arrangements needed before the day of surgery, and your fitness for anaesthesia and surgery.
The surgeon discusses the operation itself. Under 1.18.8 the hospital specialist or bariatric surgeon should go through the potential benefits, plans for conception and pregnancy where relevant, the longer-term implications and requirements of surgery, and the potential risks including perioperative mortality and complications. Family or carers can be included in that conversation.
The team recommends a procedure. NHS guidance describes the main types of weight loss surgery as gastric bypass, gastric band, gastric balloon and sleeve gastrectomy. Which one suits you depends on your weight, your conditions and your own preferences once the risks have been explained; our guide to choosing between a sleeve and a bypass sets out the criteria in detail. A gastric bypass and a sleeve carry different nutritional consequences for life, which is why the choice is settled during the assessment and reviewed with you before the date is fixed.
Why the answer differs depending on where you live
The NHS is four systems, and bariatric surgery is one of the areas where that shows. NICE guidance sets the standard in England, while each nation commissions bariatric services on its own terms and can attach its own thresholds and preparatory requirements.
NHS Wales is the sharpest illustration. Through the Welsh Institute of Metabolic and Obesity Surgery, surgery is available to adults aged 18 or over with a BMI of 40 or greater, where severe obesity has been present for at least five years, and where the patient has received and complied with an intensive weight management programme lasting at least 24 months. Approval sits with the bariatric multidisciplinary team at the Institute. Someone who would be referred for assessment in England can therefore face a materially longer preparatory route a few miles across the border.
Within England, integrated care boards commission services differently, so the local service model and the length of the specialist weight management stage vary. The formal waiting-time right is the NHS referral to treatment standard, which sets a maximum of 18 weeks from referral to the start of consultant-led treatment for non-urgent conditions. It measures the consultant-led part of the pathway; time spent beforehand in a weight management programme is not necessarily counted, which is why the full route to surgery can run well beyond 18 weeks.
A second estimate points the same way. A secondary analysis of the Health Survey for England put the number of adults meeting the eligibility criteria in 2014 at 3,623,505, or 7.78% of the population, close to a million more than under the previous guidelines (Desogus et al., 2019). Set against the 0.20% annual treatment rate reported by Currie and colleagues, the shortfall is one of service capacity rather than of disagreement over who should be treated.
What you are agreeing to when you accept surgery
The long-term follow-up attached to the referral criteria is a clinical requirement in its own right, and it is worth reading before you start the process rather than after.
NICE asks services to offer a follow-up care package for a minimum of two years within the bariatric service (1.18.17). That package covers monitoring of nutritional intake including protein and vitamins, monitoring for mineral deficiencies and for comorbidities, a medications review, individualised dietary and nutritional assessment and support, advice on physical activity, psychological support, and information about professionally led or peer-support groups. After discharge from the bariatric service, you should be offered at least annual monitoring of nutritional status and appropriate supplementation, shared between the service and your GP.
Daily vitamin and mineral supplementation and an annual blood test become permanent features of life afterwards. Our guide to life after a gastric sleeve sets out what the first months look like in practice. Substantial weight loss also leaves loose skin for many people, and reconstructive surgery after weight loss is a separate decision taken once weight has been stable, not part of the bariatric operation itself.
The reason the follow-up burden is considered proportionate is the size of the effect. A one-stage meta-analysis of 174,772 participants found metabolic-bariatric surgery associated with a 49.2% reduction in the hazard rate of death and a median life expectancy 6.1 years longer than usual care, rising to 9.3 years for people with diabetes at baseline (Syn et al., 2021). Those figures describe what happened across matched cohorts of patients who were operated on and then followed, which is the context in which your own surgeon will discuss what surgery can reasonably achieve for you.
What it costs, and what insurance actually covers
On the NHS, the surgery, the hospital stay and the follow-up appointments carry no charge, which settles the question for anyone who completes the pathway.
Private surgery in the UK has no published national tariff. Major private providers quote individually: Nuffield Health, for instance, states that the hospital or your healthcare team will give you a fixed, all-inclusive price after your initial consultation, and Spire lists gastric bypass as available to self-pay without publishing a figure. Comparing providers therefore means comparing what each quote contains, not just the headline number.
Ask any quote, in the UK or abroad, to itemise the same things: surgeon and anaesthetist fees, the hospital stay and what happens if it runs longer, pre-operative investigations, dietetic and psychological input before and after, how many months of follow-up are included, and who pays if a complication requires a return to theatre.
Private medical insurance deserves its own check. UK policies are designed around acute conditions and list what they exclude; chronic conditions and pre-existing conditions are the usual exclusion categories, and obesity may be treated as either. Read your policy’s own definitions and exclusions, and ask your insurer in writing whether bariatric surgery is covered and under what conditions, before you commit to a date. A written answer is the only one you can rely on when a claim is assessed.
If the NHS route is closed to you
Several situations end the NHS pathway before it reaches surgery: a BMI below the threshold with no qualifying condition, limits on what your local service commissions, a preparatory programme you cannot complete where one is required, or simply the length of the wait set against how fast a condition such as type 2 diabetes is progressing.
Having the operation abroad is one response, and the standard to hold a foreign provider to is the one NICE already sets for an NHS service. Check that a multidisciplinary team assesses you and that the assessment covers nutritional status and psychological readiness alongside your BMI, that a named clinician confirms your fitness for anaesthesia and surgery, that the number of months of follow-up and the form it takes are written down, that responsibility for managing a complication once you are home is stated explicitly, and that your GP will receive an operative report they can act on.
Body Expert operates in Istanbul with an English-speaking patient coordinator, arranges your hotel nights and transfers, and includes 12 months of post-operative follow-up; a written quote is provided free within 24 hours. Flights are not included and are booked by the patient.
Whichever route you take, the follow-up NICE asks of NHS patients applies to you just as much. Arrange annual nutritional monitoring with your GP, keep taking the supplements, and tell any clinician treating you that you have had bariatric surgery, because the operation can change how some medicines are absorbed. Going abroad can shorten the wait for the operation; the lifelong part of the treatment stays with you and your GP.
Sources
National Institute for Health and Care Excellence. (2025, 14 January). Overweight and obesity management (NICE guideline NG246). NICE.
NHS. (2026). Weight loss surgery. nhs.uk.
NHS 111 Wales. (2026). Weight loss surgery (bariatric surgery). NHS 111 Wales.
NHS England. (2026). Referral to treatment (RTT) waiting times. NHS England.
Currie, A. C., Askari, A., Newton, R. C., Albon, L., Hawkins, W., Slater, G., & Pring, C. M. (2021). Regional variation in unmet need for metabolic surgery in England: A retrospective, multicohort analysis. Obesity Surgery, 31(1), 439–444. https://doi.org/10.1007/s11695-020-04874-w
Desogus, D., Menon, V., Singhal, R., & Oyebode, O. (2019). An examination of who is eligible and who is receiving bariatric surgery in England: Secondary analysis of the Health Survey for England dataset. Obesity Surgery, 29(10), 3246–3251. https://doi.org/10.1007/s11695-019-03977-3
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Capristo, E., Chamseddine, G., Bornstein, S. R., & Rubino, F. (2021). Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. The Lancet, 397(10271), 293–304. https://doi.org/10.1016/S0140-6736(20)32649-0
Syn, N. L., Cummings, D. E., Wang, L. Z., Lin, D. J., Zhao, J. J., Loh, M., Koh, Z. J., Chew, C. A., Loo, Y. E., Tai, B. C., Kim, G., So, J. B.-Y., Kaplan, L. M., Dixon, J. B., & Shabbir, A. (2021). Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: A one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. The Lancet, 397(10287), 1830–1841. https://doi.org/10.1016/S0140-6736(21)00591-2